Antipsychotic Drugs Grow More Popular For Patients Without Mental Illness

Posted: Updated:
Print
Alamy
Alamy

There is a trend that alarms medical experts, policymakers and patient advocates: the skyrocketing increase in the off-label use of an expensive class of drugs called atypical antipsychotics. Until the past decade these 11 drugs, most approved in the 1990s, had been reserved for the approximately 3 percent of Americans with the most disabling mental illnesses, chiefly schizophrenia and bipolar disorder; more recently a few have been approved to treat severe depression.

Read the whole story at Washington Post

From Our Partners